Posted by: bibmomma | February 19, 2014

FDA Approves Northera for Orthostatic Hypotension In Parkinson’s Patients

From the Michael J. Fox Foundation for Parkinson’s Research Newsletter:

Yesterday the U.S. Food and Drug Administration approved the drug Northera — the brand name for droxidopa — to treat orthostatic hypotension in Parkinson’s patients.

Learn more about the FDA’s decision.

This approval after a lengthy review process is a true victory for people with Parkinson’s experiencing this common and debilitating symptom. Orthostatic hypotension is a sudden drop in blood pressure when standing, which can cause dizziness, falls and injury.

Since taking Northera can raise blood pressure when lying down, users are cautioned to sleep with their head and upper body elevated.

Tomorrow The Michael J. Fox Foundation will host a Webinar on orthostatic hypotension and other symptoms that affect the autonomic nervous system, which controls “automatic” muscle movements such as breathing and heart beat that keep us alive. Join us to hear from expert researchers and ask questions on Thursday, February 20 at 12 p.m. ET.

Register for the Webinar.


  1. FDA recently approved Novartis and Genentech’s Xolair for the treatment of chronic idiopathic urticaria, an unpredictable and debilitating skin disease that is called as chronic spontaneous urticaria outside of the US.

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s



Get every new post delivered to your Inbox.

Join 74 other followers

%d bloggers like this: